Controversies surrounding percutaneous coronary intervention in the diabetic patient

Sara C Martinez1, David R Holmes1

  • 1a Division of Cardiovascular Disease , Mayo Clinic , Rochester , MN , USA.

Insights

Diabetic patients with coronary artery disease face aggressive atherosclerosis and complications. Complete revascularization and guideline-directed medical therapy offer the best outcomes, narrowing the gap with non-diabetic patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Diabetic patients with coronary artery disease (CAD) exhibit accelerated atherosclerosis.
  • They experience higher rates of stent complications and incomplete revascularization in multivessel disease.
  • Insulin resistance significantly impacts CAD presentation and progression.

Purpose of the Study:

  • To review the pathophysiology of insulin resistance in diabetic CAD.
  • To examine revascularization strategies and their impact on diabetic patient outcomes.
  • To identify optimal treatment approaches for diabetic patients with CAD.

Main Methods:

  • Literature review focusing on pathophysiology and clinical outcomes.
  • Analysis of data on revascularization strategies in diabetic populations.
  • Synthesis of evidence regarding guideline-directed medical therapy.

Main Results:

  • Diabetic CAD is characterized by aggressive atherosclerosis and higher complication rates.
  • Revascularization strategies have evolved, with complete and durable approaches showing promise.
  • Guideline-directed medical therapy is crucial for managing diabetic CAD.

Conclusions:

  • Complete and durable revascularization is essential for improving outcomes in diabetic patients with CAD.
  • Guideline-directed medical therapy is a cornerstone of treatment.
  • Optimizing these strategies can help close the outcome gap between diabetic and non-diabetic patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
593
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
439
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
649
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K